Vapotherm Inc VAPO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if VAPO is a good fit for your portfolio.
News
-
Vapotherm Reports First Quarter 2024 Financial Results
-
Vapotherm to Unveil Access365 Home Ventilation Solution at MEDTRADE
-
Dr. David Yamane was awarded the Star Research Award at the 2024 Critical Care Congress for the presentation of the HYPERACT Study - a randomized controlled trial demonstrating Vapotherm's High Velocity Therapy effectively treats moderate-severe acute exacerbations of COPD, while improving patient comfort
-
Vapotherm's HVT 2.0 System Overcomes Regulatory Hurdles for Entry into South America's Largest Health Care Market
Trading Information
- Previous Close Price
- $0.84
- Day Range
- $0.85–0.86
- 52-Week Range
- $0.75–7.44
- Bid/Ask
- $0.86 / $0.86
- Market Cap
- $5.35 Mil
- Volume/Avg
- 15,107 / 12,493
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.08
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Vapotherm Inc is a medical technology company based in the United States. It is mainly engaged in the development and commercialization of its proprietary Hi-VNI technology products that are used to treat patients of all ages suffering from respiratory distress. The company offers four versions of its Precision Flow systems: Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, Precision Flow Heliox and others. It generates revenue from sales of products to hospitals through a direct sales organization in the United States and distributors in select countries outside of the United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 207
- Website
- https://www.vapotherm.com
Valuation
|
Metric
|
VAPO
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.08 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
VAPO
|
|---|---|
Quick Ratio | 0.10 |
Current Ratio | 0.30 |
Interest Coverage | −1.32 |
Quick Ratio
VAPO
Profitability
|
Metric
|
VAPO
|
|---|---|
Return on Assets (Normalized) | −56.38% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −45.82% |
Return on Assets
VAPO
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Jwltvttzq | Jlnzz | $181.3 Bil | |
SYK
| Stryker Corp | Hxjptlykg | Qccn | $125.8 Bil | |
BSX
| Boston Scientific Corp | Rxwwbzxy | Wjptc | $110.8 Bil | |
MDT
| Medtronic PLC | Kxlkpcnx | Zkpdtqw | $106.7 Bil | |
EW
| Edwards Lifesciences Corp | Xydxzxydxl | Rcjjdy | $52.7 Bil | |
DXCM
| DexCom Inc | Ltqmpfdqn | Qcgjp | $51.7 Bil | |
PHG
| Koninklijke Philips NV ADR | Dmzfhtzgc | Skxtqg | $25.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Hwfnnckxx | Jdq | $23.8 Bil | |
ALGN
| Align Technology Inc | Bxqvpxb | Dkpjnt | $19.9 Bil | |
PODD
| Insulet Corp | Xtykghsx | Jcgylv | $12.7 Bil |